The scientific focus adapted
to express the optimum potential
of your molecule

Marketing:
Unparalleled vision in metabolic disorders and risk assessment expertise for post-marketing studies and drug repositioning.

HeartArteryMacrophageLiverMusclePancreasAdipose Tissue

Preclinical development:
In-house predictive models and tracer technologies enable the generation of Proof of Concept efficacy data for your drugs.

Discovery:
Screening and lead validation utilize a dedicated research platform which combine with our focused scientific vision.

Home

Physiogenex provides preclinical CRO services and expertise with a 15-year expertise in evaluating drugs targeting obesity/diabetes, NASH/fibrosis, diabetic nephropathy & cardiovascular complications, dyslipidemia/atherosclerosis.

See our most popular models:

All our models are provided with benchmarks and validated in vivo experiments, biochemical assays and histology analysis/NAS scoring. Frozen/fixed biological samples from our models can be shipped to test your biomarkers and therapeutic target.

Contact us to start a collaboration

Our services to evaluate your drugs targeting

DIABETES
Insulin resistance
OBESITY

LIVER DISEASES
NAFLD
Hepatic steatosis
to fibrosis

Animal models
from basic to predictive
in-house models
Experimental platform
From gold-standard to innovative assays
Scientific expertise and translational vision